despite1 min read
Moderna CEO eyes China partnerships despite geopolitical tensions
HONG KONG -- Moderna, the U.S. biotech company known for developing an mRNA vaccine against COVID-19, is exploring partnerships in China as it broaden
By LORRETTA CHENNikkei Asia Tech

Read the full story
Originally published by Nikkei Asia Tech on Oct 22, 2026.
Comments
Sign in to join the discussion.